Thermo Fisher Scientific Inc.
TMO
Revenue
10.60B
▲57.00M▲0.5407%
3 Months ChangeAssets
100.36B
▲1.87B▲1.90%
3 Months ChangeLiabilities
51.37B
▲308.00M▲0.6032%
3 Months ChangeFree Cash Flow
904.00M
▲633.00M▲233.58%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-11-01
Form 10-Q
ID: 0000097745-24-000046
2024-10-23
Form 8-K
ID: 0000097745-24-000043
2024-08-02
Form 10-Q
ID: 0000097745-24-000040
2024-07-24
Form 8-K
ID: 0000097745-24-000036
2024-07-10
Form 8-K
ID: 0000950157-24-000978
2024-05-24
Form 8-K
ID: 0000097745-24-000026
2024-05-03
Form 10-Q
ID: 0000097745-24-000023
2024-04-24
Form 8-K
ID: 0000097745-24-000019
2024-01-31
Form 8-K
ID: 0000097745-24-000003
2023-12-05
Form 8-K
ID: 0001140361-23-056365